First Time Loading...

Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 974 INR 0.45% Market Closed
Updated: May 12, 2024

Intrinsic Value

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. [ Read More ]

The intrinsic value of one NATCOPHARM stock under the Base Case scenario is 1 304.96 INR. Compared to the current market price of 974 INR, Natco Pharma Ltd is Undervalued by 25%.

Key Points:
NATCOPHARM Intrinsic Value
Base Case
1 304.96 INR
Undervaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Natco Pharma Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NATCOPHARM stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Natco Pharma Ltd

Provide an overview of the primary business activities
of Natco Pharma Ltd.

What unique competitive advantages
does Natco Pharma Ltd hold over its rivals?

What risks and challenges
does Natco Pharma Ltd face in the near future?

Summarize the latest earnings call
of Natco Pharma Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Natco Pharma Ltd.

Provide P/S
for Natco Pharma Ltd.

Provide P/E
for Natco Pharma Ltd.

Provide P/OCF
for Natco Pharma Ltd.

Provide P/FCFE
for Natco Pharma Ltd.

Provide P/B
for Natco Pharma Ltd.

Provide EV/S
for Natco Pharma Ltd.

Provide EV/GP
for Natco Pharma Ltd.

Provide EV/EBITDA
for Natco Pharma Ltd.

Provide EV/EBIT
for Natco Pharma Ltd.

Provide EV/OCF
for Natco Pharma Ltd.

Provide EV/FCFF
for Natco Pharma Ltd.

Provide EV/IC
for Natco Pharma Ltd.

Show me price targets
for Natco Pharma Ltd made by professional analysts.

What are the Revenue projections
for Natco Pharma Ltd?

How accurate were the past Revenue estimates
for Natco Pharma Ltd?

What are the Net Income projections
for Natco Pharma Ltd?

How accurate were the past Net Income estimates
for Natco Pharma Ltd?

What are the EPS projections
for Natco Pharma Ltd?

How accurate were the past EPS estimates
for Natco Pharma Ltd?

What are the EBIT projections
for Natco Pharma Ltd?

How accurate were the past EBIT estimates
for Natco Pharma Ltd?

Compare the revenue forecasts
for Natco Pharma Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Natco Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Natco Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Natco Pharma Ltd compared to its peers.

Compare the P/E ratios
of Natco Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Natco Pharma Ltd with its peers.

Analyze the financial leverage
of Natco Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Natco Pharma Ltd.

Provide ROE
for Natco Pharma Ltd.

Provide ROA
for Natco Pharma Ltd.

Provide ROIC
for Natco Pharma Ltd.

Provide ROCE
for Natco Pharma Ltd.

Provide Gross Margin
for Natco Pharma Ltd.

Provide Operating Margin
for Natco Pharma Ltd.

Provide Net Margin
for Natco Pharma Ltd.

Provide FCF Margin
for Natco Pharma Ltd.

Show all solvency ratios
for Natco Pharma Ltd.

Provide D/E Ratio
for Natco Pharma Ltd.

Provide D/A Ratio
for Natco Pharma Ltd.

Provide Interest Coverage Ratio
for Natco Pharma Ltd.

Provide Altman Z-Score Ratio
for Natco Pharma Ltd.

Provide Quick Ratio
for Natco Pharma Ltd.

Provide Current Ratio
for Natco Pharma Ltd.

Provide Cash Ratio
for Natco Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Natco Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Natco Pharma Ltd?

What is the current Free Cash Flow
of Natco Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Natco Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Natco Pharma Ltd

Current Assets 33.5B
Cash & Short-Term Investments 12.2B
Receivables 11.3B
Other Current Assets 10.1B
Non-Current Assets 29B
Long-Term Investments 2.6B
PP&E 23.5B
Intangibles 2B
Other Non-Current Assets 978m
Current Liabilities 8.8B
Accounts Payable 3.7B
Short-Term Debt 2.4B
Other Current Liabilities 2.7B
Non-Current Liabilities 822m
Long-Term Debt 62m
Other Non-Current Liabilities 760m
Efficiency

Earnings Waterfall
Natco Pharma Ltd

Revenue
38.3B INR
Cost of Revenue
-8.3B INR
Gross Profit
30B INR
Operating Expenses
-15.8B INR
Operating Income
14.2B INR
Other Expenses
-1.4B INR
Net Income
12.8B INR

Free Cash Flow Analysis
Natco Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NATCOPHARM Profitability Score
Profitability Due Diligence

Natco Pharma Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROIC is Increasing
Exceptional 3-Years Revenue Growth
Exceptional 1-Year Revenue Growth
68/100
Profitability
Score

Natco Pharma Ltd's profitability score is 68/100. The higher the profitability score, the more profitable the company is.

NATCOPHARM Solvency Score
Solvency Due Diligence

Natco Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
99/100
Solvency
Score

Natco Pharma Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NATCOPHARM Price Targets Summary
Natco Pharma Ltd

Wall Street analysts forecast NATCOPHARM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 918.55 INR with a low forecast of 626.2 INR and a high forecast of 1 260 INR.

Lowest
Price Target
626.2 INR
36% Downside
Average
Price Target
918.55 INR
6% Downside
Highest
Price Target
1 260 INR
29% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

NATCOPHARM Price
Natco Pharma Ltd

1M 1M
0%
6M 6M
+23%
1Y 1Y
+56%
3Y 3Y
+7%
5Y 5Y
+87%
10Y 10Y
+568%
Annual Price Range
974
52w Low
617.85
52w High
1 050.3
Price Metrics
Average Annual Return 7.71%
Standard Deviation of Annual Returns 40.33%
Max Drawdown -54%
Shares Statistics
Market Capitalization 174.5B INR
Shares Outstanding 179 040 400
Percentage of Shares Shorted
N/A

NATCOPHARM Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Natco Pharma Ltd Logo
Natco Pharma Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

174.5B INR

Dividend Yield

0.52%

Description

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. The company is headquartered in Hyderabad, Telangana. The firm is engaged in the development, manufacture and commercialization of complex pharmaceuticals catering to niche therapeutic areas. The firm deals in the production of finished dosage formulations (FDF), which it sells in India, the United States and the Rest of the World, as well as active pharmaceutical ingredients (APIs). Its capabilities include multi-step synthesis, semi-synthetic fusion technologies, production of high-potency APIs and peptides. The firm operates through two segments: pharmaceuticals and agrochemicals. The pharmaceuticals segment, the Company drives its sales through FDFs and APIs. The agrochemicals segment is focused on niche products, including pest management.

Contact

TELANGANA
Hyderabad
Natco House, Road No 2, Banjara Hills
+914023547532
http://www.natcopharma.co.in/

IPO

1995-01-23

Employees

5 046

Officers

MD & Chairman
Mr. Venkaiah Chowdary Nannapaneni M. Pharm, MS.
CEO & Vice Chairman
Mr. Rajeev Nannapaneni
Chief Financial Officer
Mr. S. V. V. N. Appa Rao
President of Technical Affairs & Whole Time Director
Dr. Donthineni Linga Rao M.D.
Company Secretary & Compliance Officer
Mr. Chekuri Venkat Ramesh C.S.
Executive VP of Corporate Engineering Services & Whole Time Director
Mr. Potluri Sivaramakrishna Prasad
Show More
Executive VP of Technical Operations & Director
Dr. Pavan Ganapati Bhat
Senior Vice President of Operations
Sanivarapu Raviprakash Reddy
Executive Vice President of Corporate Affairs, Legal, Secretarial & Estate Management
N. Sadasiva Rao
Vice President of Marketing & Sales - Domestic
James Rajakumar
Show Less

See Also

Discover More
What is the Intrinsic Value of one NATCOPHARM stock?

The intrinsic value of one NATCOPHARM stock under the Base Case scenario is 1 304.96 INR.

Is NATCOPHARM stock undervalued or overvalued?

Compared to the current market price of 974 INR, Natco Pharma Ltd is Undervalued by 25%.